

DiathevaisanItalianbiotechnologycompanylocatedinFano(PU)foundedin2002withtheaimtobringresearchintoindustrialproductsbycooperatingwithfirms,publicandprivateresearchinstitutions.
Diathevafocusesondevelopment,productionandmarketingofnewandinnovativeproductsfordiagnostic,researchandtherapeuticapplicationsinthefieldof:Cancer,MicrobialInfectionandPharmacogenetics,providingawiderangeofreagentsandkitsforHIV-Istudy,pharmacogenetictestsforpersonalizedandpredictivemedicineandinnovativesolutionsforfoodsafety.
Sinceitsfoundation,Diathevahasbeeninvestingmanyresourcesinr&dactivities:inparticularthecompanyhasappliedwithsuccesstomanyfundedEuropeanandnationalresearchprojectsenlargingitscollaborativeandcommercialnetworkandacquiringanupdatedknow-how.
In2009incollaborationwithotherbiotechfirmsintheMarcheRegionDiathevafoundedMarcheBIOTECH,anindependent,non-profitassociationwiththeaimtopromotethebioscienceindustryinItaly,toexpandtheknowledgeandexpertiseofMarchesbusiness,concerningthelifesciences.
In2012DiathevawasacquiredfromSOLspa,themostinnovativeproviderofgasesintheindustrialandmedicalsectors.
DiathevahasaGMPfacility,authorizedbyAIFA,toproduceandreleaseAPIsforpre-clinicalandclinicaltrialswithaspecialemphasisonnewimmunogensagainstHIVandothermicrobialpathogens.Atpresent,Diathevahastwopromisinganti-cancerscFvantibodyinclinicaltrialstudiesandonescFvantibodyforthetreatmentofCandidaAlbicansindiscovery.
Thecompanyhastheexperience,expertise,capacity,andflexibilitytoserveasstrategicpartnerfordrugdevelopmentandmanufacturingneeds.
Diathevahasadiversifiedrangeofactivities,itsmainbusinessmodelisbasedondevelopment,manufacturingandmarketingofinnovativediagnosticskits.ThecompanyhasalsosignedseveralR&DandGMPmanufacturingcontractswithItalianandforeigncompanies.
DIATHEVA’steamiscomposedbyqualifiedbiologists,dynamicandcomplementary,witharobustscientificbackgroundandawiderangeofskills.